GLP-1 and Exercise — Do You Still Need to Work Out?

Inception Point AI
  • 0.0 (0)
  • Fitness

GLP-1 medications like Ozempic can trigger significant weight loss, but up to 39% may come from muscle, not fat. Maverick Ryder reveals why resistance training and strategic nutrition are essential to protect your metabolic health, preserve strength, and maintain results long after the shot ends. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Episodes

  1. Apr 7

    GLP-1 and Exercise — Discover whether you still need to sweat it out with Maverick "Mav" Ryder

    Join Maverick "Mav" Ryder as he exposes the hidden truth about GLP-1 weight loss drugs like Ozempic and Wegovy. Discover why up to 40% of your weight loss could be muscle mass, and learn essential strategies to protect your strength while these medications work. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

  2. Apr 7

    GLP-1 and Exercise — Do You Still Need to Work Out? - What Happens When You Stop the Shot

    Maverick Ryder explores what happens when GLP-1 medications stop, examining research showing 67% weight regain within one year. Learn why combining strength training and cardio with medication builds sustainable muscle mass, metabolic resilience, and lasting habits that preserve results long after the prescription ends. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

  3. Apr 7

    GLP-1 and Exercise - Fueling the Machine When You're Never Hungry

    Host Maverick Ryder explores the critical muscle-loss risk facing GLP-1 users, revealing that up to 39% of weight lost can be lean tissue. Drawing from 2024 research, Mav delivers science-backed strategies for protein intake, workout timing, and eating when appetite vanishes—protecting the metabolic engine while medications reshape your body. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

  4. Apr 7

    GLP-1 and Exercise — Do You Still Need to Work Out? - The Muscle You Can't Afford to Lose

    Maverick Ryder delivers an urgent wake-up call about GLP-1 medications like Ozempic and Wegovy: up to 39% of weight loss can be muscle, not fat, without resistance training. He breaks down why this matters and provides actionable strategies to preserve strength while losing weight safely and sustainably. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

  • 1 Trailer
    3 Episodes

Trailer

About

GLP-1 medications like Ozempic can trigger significant weight loss, but up to 39% may come from muscle, not fat. Maverick Ryder reveals why resistance training and strategic nutrition are essential to protect your metabolic health, preserve strength, and maintain results long after the shot ends. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Information